Sources
58 main bibliography references · 12 additional references. 33 FAQ audit references with independent numbering
- Main bibliography · [1] Citations and related combinations →
[1] White WE. The Dextromethorphan FAQ. Text Version 4.0. 1997. Historical source; Section 13 and related warnings. Includes user reports.
- Main bibliography · [2] Citations and related combinations →
[2] AUVELITY prescribing information. DailyMed. Prescribing information: serotonin toxicity, MAOIs, CYP2D6, and bupropion. Accessed 2 October 2026. Source
- Main bibliography · [3] Citations and related combinations →
[3] O’Mathúna B et al. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans. J Clin Psychopharmacol. 2008;28(5):523–529. DOI 10.1097/JCP.0b013e318184ff6e. Human pharmacokinetic study; abstract and selected full-text methods, results and discussion checked for this proposed revision. Bibliographic pages: 523–529; the publisher PDF is printed as 525–531. Source
- Main bibliography · [4] Citations and related combinations →
[4] NUEDEXTA prescribing information. DailyMed. Prescribing information: metabolism, MAOIs, serotonin toxicity, and QT. Accessed 2 October 2026. Source
- Main bibliography · [5] Citations and related combinations →
[5] Rickli A et al. Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome. Br J Pharmacol. 2018;175:532–543. DOI 10.1111/bph.14105. In vitro transporter experiments and clinical reports. Source
- Main bibliography · [6] Citations and related combinations →
[6] Monte AA, Chuang R, Bodmer M. Dextromethorphan, chlorphenamine and serotonin toxicity: case report and systematic literature review. Br J Clin Pharmacol. 2010;70:794–798. DOI 10.1111/j.1365-2125.2010.03747.x. Cases primarily involve overdose. Source
- Main bibliography · [7] Citations and related combinations →
[7] Jung JK, Zazay I, Burmeister JR, Shaghaghi N. Serotonin syndrome induced by Bromfed DM in a patient on sertraline. SAGE Open Medical Case Reports. 2025. DOI 10.1177/2050313X251392069. Single case involving a multicomponent syrup. Source
- Main bibliography · [8] Citations and related combinations →
[8] Halman A et al. Drug–drug interactions involving classic psychedelics: A systematic review. 2024. DOI 10.1177/02698811231211219. General interaction literature; not a DXM combination trial. Source
- Main bibliography · [9] Citations and related combinations →
[9] Shen HW, Jiang XL, Winter JC, Yu AM. Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab. 2010;11(8):659–666. DOI 10.2174/138920010794233495. Source
- Main bibliography · [10] Citations and related combinations →
[10] Bansal S et al. Evaluation of Cytochrome P450 Mediated Cannabinoid Drug Interactions in Healthy Adult Participants. Clin Pharmacol Ther. 2023;114:693–703. DOI 10.1002/cpt.2973. Human CYP-probe study. Source
- Main bibliography · [11] Citations and related combinations →
[11] Felmlee MA, Morse BL, Morris ME. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology. AAPS J. 2021;23(1):22. DOI 10.1208/s12248-020-00543-z. Source
- Main bibliography · [12] Citations and related combinations →
[12] FDA. Gabapentin and Pregabalin Drug Safety Communication. Respiratory safety warning; not a DXM study. Source
- Main bibliography · [13] Citations and related combinations →
[13] UK Advisory Council on the Misuse of Drugs. Nitrous oxide updated harms assessment. 2023. Hypoxia and B12-related harms; not a DXM study. Source
- Main bibliography · [14] Citations and related combinations →
[14] NAMENDA prescribing information. DailyMed. Prescribing information notes insufficient assessment of NMDA-antagonist combinations. Accessed 2 October 2026. Source
- Main bibliography · [15] Citations and related combinations →
[15] Suzuki J et al. Toxicities associated with NBOMe ingestion—a novel class of potent hallucinogens: a review of the literature. Psychosomatics. 2015. PMID 25659919. Source
- Main bibliography · [16] Citations and related combinations →
[16] Moss MJ, Hendrickson RG. Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002–2016. Clin Toxicol (Phila). 2019;57(2):99–103. Published online 2018. DOI 10.1080/15563650.2018.1497169. Source
- Main bibliography · [17] Citations and related combinations →
[17] Johnson MW, MacLean KA, Reissig CJ, Prisinzano TE, Griffiths RR. Human psychopharmacology and dose-effects of salvinorin A, a kappa-opioid agonist hallucinogen present in the plant Salvia divinorum. Drug Alcohol Depend. 2011;115:150–155. Source
- Main bibliography · [18] Citations and related combinations →
[18] Hamelin BA et al. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther. 2000;67(5):466–477. DOI 10.1067/mcp.2000.106464. Source
- Main bibliography · [19] Citations and related combinations →
[19] Schadel M, Wu D, Otton SV, Kalow W, Sellers EM. Pharmacokinetics of dextromethorphan and metabolites in humans: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol. 1995;15(4):263–269. DOI 10.1097/00004714-199508000-00005. Source
- Main bibliography · [20] Citations and related combinations →
[20] Shiran MR et al. A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment. Br J Clin Pharmacol. 2003. PMID 12895196. Source
- Main bibliography · [21] Citations and related combinations →
[21] Grossman E et al. Oral yohimbine increases blood pressure and sympathetic nervous outflow in hypertensive patients. J Cardiovasc Pharmacol. 1993. PMID 7690091. Source
- Main bibliography · [22] Citations and related combinations →
[22] Di Marco MP, Edwards DJ, Wainer IW, Ducharme MP. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein. Life Sci. 2002;71(10):1149–1160. DOI 10.1016/S0024-3205(02)01799-X. Source
- Main bibliography · [23] Citations and related combinations →
[23] Cai WM, Chen B, Ling SS, Zhang YD. Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects. Br J Clin Pharmacol. 2001;51(1):107–108. DOI 10.1046/j.1365-2125.2001.01322.x. Source
- Main bibliography · [24] Citations and related combinations →
[24] Jacqz-Aigrain E, Funck-Brentano C, Cresteil T. CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans. Pharmacogenetics. 1993;3(4):197–204. DOI 10.1097/00008571-199308000-00004. Source
- Main bibliography · [25] Citations and related combinations →
[25] American College of Medical Toxicology. Dextromethorphan FAQ. Educational material on poisoning and interactions. Source
- Main bibliography · [26] Citations and related combinations →
[26] RASAGILINE prescribing information. DailyMed. DXM contraindication, including psychosis and unusual behavior warnings. Accessed 2 October 2026. Source
- Main bibliography · [27] Citations and related combinations →
[27] Harada T et al. A fatal intoxication case due to the serotonin syndrome induced by dextromethorphan and moclobemide overdose. Leg Med (Tokyo). 2025;74:102604. DOI 10.1016/j.legalmed.2025.102604. Postmortem overdose report; not an estimate of outcome frequency. Source
- Main bibliography · [28] Citations and related combinations →
[28] Capon DA, Bochner F, Kerry N, Mikus G, Danz C, Somogyi AA. The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Clin Pharmacol Ther. 1996;60(3):295–307. PMID 8841152. DOI 10.1016/S0009-9236(96)90056-9. PK comparison between phenotypes and the effect of quinidine. Source
- Main bibliography · [29] Citations and related combinations →
[29] Tanna RS et al. Clinical Assessment of the Drug Interaction Potential of the Psychotropic Natural Product Kratom. Clin Pharmacol Ther. 2023;113:1315–1325. DOI 10.1002/cpt.2891. DXM as a probe after one low kratom exposure. Source
- Main bibliography · [30] Citations and related combinations →
[30] ONDANSETRON prescribing information. DailyMed. QT effects and regulatory serotonin-syndrome warning. Accessed 2 October 2026. Source
- Main bibliography · [31] Citations and related combinations →
[31] Rojas-Fernandez CH. Can 5-HT3 Antagonists Really Contribute to Serotonin Toxicity? A Call for Clarity and Pharmacological Law and Order. Drugs Real World Outcomes. 2014;1:3–5. DOI 10.1007/s40801-014-0004-3. Source
- Main bibliography · [32] Citations and related combinations →
[32] SCOPOLAMINE prescribing information. DailyMed. Anticholinergic effects, hyperthermia, and CNS interactions; extrapolation to DXM. Accessed 2 October 2026. Source
- Main bibliography · [33] Citations and related combinations →
[33] PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE prescribing information. DailyMed. Sedation and other warnings for the therapeutic combination product. Accessed 2 October 2026. Source
- Main bibliography · [34] Citations and related combinations →
[34] ZELAPAR selegiline prescribing information. DailyMed. DXM contraindication and limits of MAO-B selectivity. Accessed 2 October 2026. Source
- Main bibliography · [35] Citations and related combinations →
[35] Khoshnam-Rad N et al. Datura poisoning in a family: Case series and literature review. Clin Case Rep. 2022. DOI 10.1002/ccr3.6091. Source
- Main bibliography · [36] Citations and related combinations →
[36] Health Canada. Canada launches new toll-free 1-844 POISON-X number for poison centres. 2023. Canadian poison-centre numbers and availability. Source
- Main bibliography · [37] Citations and related combinations →
[37] National Capital Poison Center. Use acetaminophen safely: Tips to prevent poisoning. Absence of early symptoms and prompt consultation for suspected overdose. Source
- Main bibliography · [38] Citations and related combinations →
[38] National Capital Poison Center. First aid: Act fast! Immediate emergency response to collapse, seizures, impaired breathing, or inability to awaken. Source
- Main bibliography · [39] Citations and related combinations →
[39] Hendershot PE, Antal EJ, Welshman IR, Batts DH, Hopkins NK. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr. J Clin Pharmacol. 2001;41(5):563–572. DOI 10.1177/00912700122010302. Source
- Main bibliography · [40] Citations and related combinations →
[40] LINEZOLID prescribing information. DailyMed. Direct DXM interaction findings in healthy volunteers. Accessed 2 October 2026. Source
- Main bibliography · [41] Citations and related combinations →
[41] Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007. DOI 10.1038/sj.bjp.0707430. Source
- Main bibliography · [42] Citations and related combinations →
[42] Rivers N, Horner B. Possible lethal reaction between nardil and dextromethorphan. Can Med Assoc J. 1970;103(1):85. PMID 20311659. Source
- Main bibliography · [43] Citations and related combinations →
[43] Härtter S, Dingemanse J, Baier D, Ziegler G, Hiemke C. Inhibition of dextromethorphan metabolism by moclobemide. Psychopharmacology. 1998;135:22–26. DOI 10.1007/s002130050481. Source
- Main bibliography · [44] Citations and related combinations →
[44] XADAGO (safinamide) prescribing information. DailyMed. DXM contraindication and psychiatric rationale. Accessed 2 October 2026. Source
- Main bibliography · [45] Citations and related combinations →
[45] Aarnoutse RE et al. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers. Clin Pharmacol Ther. 2005;78(6):664–674. DOI 10.1016/j.clpt.2005.09.001. Source
- Main bibliography · [46] Citations and related combinations →
[46] Wyen C et al. Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients. Clin Pharmacol Ther. 2008. DOI 10.1038/sj.clpt.6100452. PMID 18183034. Source
- Main bibliography · [47] Citations and related combinations →
[47] Canadian Association for Poison Centres and Clinical Toxicology. Poison-centre contacts and Nunavut public-access instructions. Accessed 2 October 2026. National contacts · Ontario centre and Nunavut instructions
- Main bibliography · [48] Citations and related combinations →
[48] Health Canada. About the Good Samaritan Drug Overdose Act; Department of Justice Canada. Controlled Drugs and Substances Act, section 4.1. Accessed 2 October 2026. Official guidance · Statutory definition and protections
- Main bibliography · [49] Citations and related combinations →
[49] Supreme Court of Canada. R. v. Wilson, 2025 SCC 32. 24 October 2025. Official case summary. Source
- Main bibliography · [50] Citations and related combinations →
[50] Amchin J et al. Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe. J Clin Pharmacol. 2001;41(4):443–451. DOI 10.1177/00912700122010159. Source
- Main bibliography · [51] Citations and related combinations →
[51] Tramadol hydrochloride tablets prescribing information. DailyMed. Prescribing information: 07/2024; Medication Guide: 10/2025. Accessed 16 October 2026. Source
- Main bibliography · [52] Citations and related combinations →
[52] DEMEROL oral prescribing information. DailyMed. Prescribing information: 03/2021; oral tablets and solution. Accessed 16 October 2026. Source
- Main bibliography · [53] Citations and related combinations →
[53] DOLOPHINE prescribing information. DailyMed. Prescribing information: 06/2021; Medication Guide: 12/2022. Accessed 16 October 2026. Source
- Main bibliography · [54] Citations and related combinations →
[54] Codeine sulfate tablets prescribing information. Hikma Pharmaceuticals USA Inc. DailyMed. Revised 12/2025; updated 22 December 2025. Sections 5.2, 5.3, 5.6, 5.7, 12.3. Accessed 16 October 2026. Source
- Main bibliography · [55] Citations and related combinations →
[55] Crews KR et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy. Clin Pharmacol Ther. 2021;110(4):888–896. DOI 10.1002/cpt.2149. CPIC author PDF; pages 3–4, Codeine and Table 2. Source
- Main bibliography · [56] Citations and related combinations →
[56] Kolaczynska KE, Thomann J, Hoener MC, Liechti ME. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative. Int J Mol Sci. 2021;22(15):8277. DOI 10.3390/ijms22158277. Human-transporter cell experiments. Source
- Main bibliography · [57] Citations and related combinations →
[57] Beck O, Franzén L, Bäckberg M, Signell P, Helander A. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol (Phila). 2016;54(7):568–575. DOI 10.1080/15563650.2016.1190979. Abstract accessed 16 October 2026; full text not read. Source
- Main bibliography · [58] Citations and related combinations →
[58] Franzén L, Bäckberg M, Beck O, Helander A. Acute Intoxications Involving α-Pyrrolidinobutiophenone (α-PBP): Results from the Swedish STRIDA Project. J Med Toxicol. 2018;14(4):265–271. DOI 10.1007/s13181-018-0668-2. Aggregate co-detection table; patient-level overlap of α-PVP and DXM unspecified. Source
- Additional reference Citations and related combinations →
India: Ministry of Home Affairs, Press Information Bureau. Shri Amit Shah launches Emergency Response Support System (ERSS - Dial 112), E-Beat Book System and E-Saathi App. 20 September 2019. Accessed 2026-10-19. https://www.pib.gov.in/PressReleasePage.aspx?PRID=1585706
- Additional reference Citations and related combinations →
CAPCCT national contacts. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
CAPCCT Ontario centre / Nunavut public route. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
CAPCCT Québec centre. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
China: State Council. Making phone calls in China. Inspected 2026-10-16. https://english.www.gov.cn/services/liveinchina/202008/04/content_WS5f29094bc6d029c1c2637342.html
- Additional reference Citations and related combinations →
Health Canada Good Samaritan guidance. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
Health Canada POISON-X announcement. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
Justice Canada CDSA section 4.1. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
Nunavut community health centres. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
Supreme Court of Canada R. v. Wilson official Case in Brief. Accessed 2026-10-04.
- Additional reference Citations and related combinations →
USA: National 911 Program. Calling 911. Inspected 2026-10-16. https://www.911.gov/calling-911/
- Additional reference Citations and related combinations →
МЧС России. Как правильно вызвать скорую? Accessed 2026-10-05.
- Making phone calls in China
- Emergency Response Support System (ERSS - Dial 112): official MHA press release
- Health Canada Good Samaritan guidance
- Justice Canada CDSA section 4.1
- CAPCCT national contacts
- Nunavut community health centres
- CAPCCT Ontario centre / Nunavut public route
- Health Canada POISON-X announcement
- CAPCCT Québec centre
- Как правильно вызвать скорую?
- Calling 911
- Supreme Court of Canada R. v. Wilson official Case in Brief